SKHX Slips to $1,482, Trading Under the ADR Price SK hynix Just Set for Its Nasdaq Debut

SK hynix Just Put a Price on the Biggest Foreign US Listing Ever

On July 6, SK hynix filed a revised prospectus that trimmed its Nasdaq raise to 43.14 trillion won, about $28.14 billion, down from an original 45.45 trillion won, and set an indicative ADR price of ₩242,500 (roughly $158.26). One domestic common share splits into 10 ADRs, so that indicative price pegs the reference at about ₩2.42 million — near $1,583 — per share, which is exactly the underlying SKHX tracks. Even after the downsizing, this remains the largest-ever initial US stock sale by a foreign company, ahead of Alibaba and Saudi Aramco's records, with roughly 17.79 million new shares (about 2.5% of the float) and a July 10 Nasdaq debut. The cut wasn't a change of heart — the company simply marked the raise to a reference share that had already faded from ₩2.55 million on June 23 to ₩2.42 million by July 3.

The Perp Is Trading Below Its Own Listing Price

At $1,482, SKHX sits roughly 6% under the ~$1,583 per-share level implied by the indicative ADR price. That gap is the market's read on pricing risk into a bookbuild that hasn't closed yet — you don't usually see the tracker trade above the number until the deal is done. It's also downstream of a genuinely ugly week for memory: on July 2, SK hynix and Samsung shares fell more than 9% as an AI-capex scare — stoked partly by reports Meta is reselling excess compute — dragged the Kospi down hard. Fortune reported SK hynix itself signaled it would slow its AI-memory expansion, a headline that helped trigger one of the Kospi's worst sessions on record. Seoul bounced the next day, but the perp is still bleeding the pre-listing overhang rather than trading a fresh fundamental.

What Listing Week Puts in Play

The bear case is froth. Capital Economics flagged "excessive" volatility and BofA warned of a snapback — the classic worry that a record raise marks a cycle top. But the underlying still ran roughly 770% over the past twelve months, outpacing Micron, and the ~$28 billion is earmarked for HBM capacity — the Yongin Y1 fab and Cheongju advanced-packaging line — not a defensive war chest. Read straight, SKHX at these levels is discounting execution risk on a record foreign listing, not a break in AI-memory demand. One caveat specific to this contract: SKHX converts a KRW-denominated share price into USD, so a slice of any move is FX drift and thin-book noise rather than a repricing of SK hynix itself — worth remembering before treating a 4.89% slide as a verdict.